Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Arcaini

Showing results (11-20 of 262) with videos related to

Pageof 27
Sort By:
Current Clinical Pharmacology|February 17, 2010
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomasLuca Arcaini, Raffaele Bruno
Leukemia & Lymphoma|September 29, 2021
The double significance of idelalisib immune-related toxicityMichele Merli, Francesco Passamonti, Luca Arcaini
Therapeutic Advances in Hematology|April 8, 2016
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Barbara Vannata, Luca Arcaini, Emanuele Zucca
Blood|March 19, 2016
Splenic marginal zone lymphoma: from genetics to managementLuca Arcaini, Davide Rossi, Marco Paulli
British Journal of Haematology|November 1, 2020
Antiviral prophylaxis for hepatitis B carriers affected by diffuse large B cell lymphoma: a matter of survivalValentina Zuccaro, Raffaele Bruno, Luca Arcaini
British Journal of Haematology|August 18, 2023
Deciphering molecular complexity of HCV-associated lymphoproliferationMichele Merli, Francesco Passamonti, Luca Arcaini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2022
Reply to M. Shibusawa et alStefano Luminari, Luca Arcaini, Massimo Federico
Expert Opinion on Pharmacotherapy|June 14, 2021
Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphomaChiara Cavalloni, Marzia Varettoni, Sara Rattotti, et al.
Thescientificworldjournal|August 25, 2012
Prognostic assessment in patients with indolent B-cell lymphomasLuca Arcaini, Sara Rattotti, Manuel Gotti, et al.
World Journal of Gastroenterology|October 28, 2016
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphomaMichele Merli, Giuseppe Carli, Luca Arcaini, et al.
Pageof 27

Showing results (11-20 of 262) with videos related to

Sort By:
Pageof 27
Current Clinical Pharmacology|February 17, 2010
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomasLuca Arcaini, Raffaele Bruno
Leukemia & Lymphoma|September 29, 2021
The double significance of idelalisib immune-related toxicityMichele Merli, Francesco Passamonti, Luca Arcaini
Therapeutic Advances in Hematology|April 8, 2016
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Barbara Vannata, Luca Arcaini, Emanuele Zucca
Blood|March 19, 2016
Splenic marginal zone lymphoma: from genetics to managementLuca Arcaini, Davide Rossi, Marco Paulli
British Journal of Haematology|November 1, 2020
Antiviral prophylaxis for hepatitis B carriers affected by diffuse large B cell lymphoma: a matter of survivalValentina Zuccaro, Raffaele Bruno, Luca Arcaini
British Journal of Haematology|August 18, 2023
Deciphering molecular complexity of HCV-associated lymphoproliferationMichele Merli, Francesco Passamonti, Luca Arcaini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2022
Reply to M. Shibusawa et alStefano Luminari, Luca Arcaini, Massimo Federico
Expert Opinion on Pharmacotherapy|June 14, 2021
Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphomaChiara Cavalloni, Marzia Varettoni, Sara Rattotti, et al.
Thescientificworldjournal|August 25, 2012
Prognostic assessment in patients with indolent B-cell lymphomasLuca Arcaini, Sara Rattotti, Manuel Gotti, et al.
World Journal of Gastroenterology|October 28, 2016
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphomaMichele Merli, Giuseppe Carli, Luca Arcaini, et al.
Pageof 27